{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:35:36Z","timestamp":1787841336748,"version":"build-2784847793"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"abstract":"\n BACKGROUND:<\/jats:title>\n Oral and oropharyngeal carcinomas representing about 90% of all oral malignancies are the sixth most common cancers worldwide. Basic modalities of cancer treatment are surgery, radiotherapy, and chemotherapy (CT) either alone or in combination. For squamous cell carcinoma (SCC) patients, induction CT followed by radiotherapy and concurrent CT are effective methods for improving response rates.<\/jats:p>\n <\/jats:sec>\n \n MATERIALS AND METHODS:<\/jats:title>\n \n Fifty patients with advance stage oral cavity cancer with performance status >60% on Karnofsky performance scale and having no prior exposure to CT, radiotherapy, and surgery were included in the study. CT including bleomycin, methotrexate, and cisplatin was given on day 1 and repeated at an interval of 21 days. After the completion of three cycles, two groups (\n n<\/jats:italic>\n = 25 each) were formed. One group was treated with radiotherapy alone and other group of patients treated with radiotherapy and concurrent cisplatin infusion. The patient toxicities and response were evaluated.\n <\/jats:p>\n <\/jats:sec>\n \n RESULTS:<\/jats:title>\n After completion of induction CT, both the groups responded with almost similar result. Nausea, vomiting, mucositis, and skin reactions during radiotherapy were observed in both groups but comparatively higher in Group \u201cB.\u201d In Group B, 84% (vs. 60% in Group A) of patients showed complete response (CR) after completion of treatment, and out of 13 patients who responded partially to induction CT, 9 patients showed CR after concurrent chemoradiotherapy.<\/jats:p>\n <\/jats:sec>\n \n CONCLUSION:<\/jats:title>\n This study showed the superiority of induction followed by concurrent chemoradiotherapy over induction plus radiotherapy alone in the treatment of advanced oral cavity neck SCC.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijc.ijc_166_17","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:43:22Z","timestamp":1513817002000},"page":"16-19","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Impact of induction chemotherapy to concurrent chemoirradiation over radiotherapy alone in advanced oral cavity"],"prefix":"10.4103","volume":"54","author":[{"given":"MS","family":"Rewadkar","sequence":"first","affiliation":[{"name":"Department of Radiotherapy, Cama and Albless Hospital, Mumbai, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VK","family":"Mahobia","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Government Medical College and Hospital, Nagpur, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"R1-20250920","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","article-title":"Global epidemiology of oral and oropharyngeal cancer","volume":"45","author":"Warnakulasuriya","year":"2009","journal-title":"Oral Oncol"},{"key":"R2-20250920","doi-asserted-by":"crossref","first-page":"316","DOI":"10.4103\/0970-9290.70782","article-title":"Trends in the epidemiology of oral squamous cell carcinoma in Western UP: An institutional study","volume":"21","author":"Sharma","year":"2010","journal-title":"Indian J Dent Res"},{"key":"R3-20250920","doi-asserted-by":"crossref","first-page":"e78999","DOI":"10.1371\/journal.pone.0078999","article-title":"The magnitude of tobacco smoking-betel quid chewing-alcohol drinking interaction effect on oral cancer in South-East Asia. A meta-analysis of observational studies","volume":"8","author":"Petti","year":"2013","journal-title":"PLoS One"},{"key":"R4-20250920","doi-asserted-by":"crossref","first-page":"81","DOI":"10.5005\/jp-journals-10011-1100","article-title":"Correlation of clinical patterns of oral squamous cell carcinoma with age, site, sex and habits","volume":"23","author":"Mathur","year":"2011","journal-title":"J Indian Acad Oral Med Radiol"},{"key":"R5-20250920","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: The 7th edition of the AJCC Cancer Staging Manual and the Future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"R7-20250920","first-page":"117","article-title":"Advances in radiation therapy: Conventional to 3D, to IMRT, to 4D, and beyond","volume":"55","author":"Bucci","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"R8-20250920","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.coms.2012.01.003","article-title":"An update on squamous carcinoma of the oral cavity, oropharynx, and maxillary sinus","volume":"24","author":"Lubek","year":"2012","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"R10-20250920","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa071028","article-title":"Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer","volume":"357","author":"Vermorken","year":"2007","journal-title":"N Engl J Med"},{"key":"R11-20250920","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMra0707975","article-title":"Recent advances in head and neck cancer","volume":"359","author":"Haddad","year":"2008","journal-title":"N Engl J Med"},{"key":"R12-20250920","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa070956","article-title":"Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer","volume":"357","author":"Posner","year":"2007","journal-title":"N Engl J Med"},{"key":"R13-20250920","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0959-8049(05)80350-8","article-title":"Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study","volume":"29A","author":"Paccagnella","year":"1993","journal-title":"Eur J Cancer"},{"key":"R14-20250920","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/annonc\/mdp573","article-title":"Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally advanced head and neck cancer: A phase II randomized study","volume":"21","author":"Paccagnella","year":"2010","journal-title":"Ann Oncol"},{"key":"R15-20250920","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0360-3016(91)90133-O","article-title":"Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: Long-term follow-up of RTOG study 73-03","volume":"20","author":"Tupchong","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/02223310-201754010-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:49:23Z","timestamp":1787838563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/02223310-201754010-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/ijc.ijc_166_17","relation":{},"ISSN":["0019-509X","1998-4774"],"issn-type":[{"value":"0019-509X","type":"print"},{"value":"1998-4774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}